Korean J Crit Care Med.  2007 Dec;22(2):96-100.

Successful Empirical Treatment of Intravenous Immune Globulin in Recent-Onset Idiopathic Dilated Cardiomyopathy: A Case Report

Affiliations
  • 1Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea. jhs2003@hanyang.ac.kr

Abstract

Intravenous immunoglobulin (IVIG) therapy has been introduced to idiopathic dilated cardiomyopathy due to their antiviral and anti-inflammatory effects. But each study reported conflicting result and treatment regimen has not been clearly established. We experienced a case of 28-year-old woman with idiopathic dilated cardiomyopathy with severely depressed cardiac function. Its onset time was obvious within 1 month. Despite of conservative treatment of heart failure, sudden cardiac arrest was developed. We tried IVIG therapy, and her symptoms and cardiac function were improved after IVIG treatment.

Keyword

Acute myocarditis; Idiopathic dilated cardiomyopathy; Immunoglobulin

MeSH Terms

Adult
Cardiomyopathy, Dilated*
Death, Sudden, Cardiac
Female
Heart Failure
Humans
Immunoglobulins
Immunoglobulins, Intravenous*
Immunoglobulins
Immunoglobulins, Intravenous
Full Text Links
  • KJCCM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr